Pietro Quaglino

Research interests

Publications

• EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

  European Journal of Cancer · 2023 · https://doi.org/10.1016/j.ejca.2023.113343

• Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00065-6

• Cutaneous T cell lymphoma

  Nature Reviews Disease Primers · 2021 · https://doi.org/10.1038/s41572-021-00296-9

• Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

  Blood · 2021 · https://doi.org/10.1182/blood.2021012057

• Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force

  European Journal of Cancer · 2018 · https://doi.org/10.1016/j.ejca.2018.01.076

• Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

  Acta Oncologica · 2018 · https://doi.org/10.1080/0284186x.2018.1454602

• The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

  British Journal of Dermatology · 2018 · https://doi.org/10.1111/bjd.17258

• European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

  European Journal of Cancer · 2017 · https://doi.org/10.1016/j.ejca.2017.02.027

• Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31266-7

• European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14466

• Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx352

• European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14458

• Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31266-7

• Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

  JAMA Dermatology · 2015 · https://doi.org/10.1001/jamadermatol.2015.1916

• Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.61.7142

• Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?

  British Journal of Dermatology · 2014 · https://doi.org/10.1111/bjd.12909

• Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome

  Clinical & Experimental Immunology · 2014 · https://doi.org/10.1111/cei.12394

• Guidelines on the use of extracorporeal photopheresis

  Journal of the European Academy of Dermatology and Venereology · 2013 · https://doi.org/10.1111/jdv.12311

• Giornale italiano di Dermatologia e Venereologia

  Institutional Research Information System University of Turin (University of Turin) · 2012

• Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea

  British Journal of Dermatology · 2010 · https://doi.org/10.1111/j.1365-2133.2010.09633.x

• Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study

  Annals of Oncology · 2009 · https://doi.org/10.1093/annonc/mdp325

• Electrochemotherapy with Intravenous Bleomycin in the Local Treatment of Skin Melanoma Metastases

  Annals of Surgical Oncology · 2008 · https://doi.org/10.1245/s10434-008-9976-0

• Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patients

  Haematologica · 2007 · https://doi.org/10.3324/haematol.11127

• Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

  British Journal of Dermatology · 2006 · https://doi.org/10.1111/j.1365-2133.2006.07398.x

• Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.6285

• The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells

  British Journal of Dermatology · 2001 · https://doi.org/10.1046/j.1365-2133.2001.04014.x

Current projects

No projects listed.